Clinical trials
Phase 1 Esophageal Squamous Cell Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 14 |
| Terminated | 12 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Exelixis | 2 |
| IDEAYA Biosciences | 2 |
| Incyte Corporation | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| ALX Oncology Inc. | 1 |
| AbbVie | 1 |
| Albany Medical College | 1 |
| Atreca, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 44 |
| Carcinoma, Non-Small-Cell Lung | 21 |
| Squamous Cell Carcinoma of Head and Neck | 18 |
| Stomach Neoplasms | 12 |
| Esophageal Neoplasms | 11 |
| Triple Negative Breast Neoplasms | 11 |
| Colorectal Neoplasms | 10 |
| Neoplasm Metastasis | 10 |
| Uterine Cervical Neoplasms | 10 |
| Carcinoma, Hepatocellular | 8 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.